Nathan D. Mathewson

机构：Atara Biotherapeutics (United States) · ORCID：0000-0002-8895-2609

发表论文 183 篇 · 总被引 5778 次 · h-index 25

代表论文

Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure (2025 · Cell Reports Medicine · 被引 14)
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma (2025 · Cancer Cell · 被引 3)
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates (2024 · Blood · 被引 3)
Data from IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity (2024 · 被引 1)
Cis-targeted IL-2 Mutein to Augment the Antitumor Activity of Engineered T Cells (2026 · Transplantation and Cellular Therapy)
Table S1 from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer (2026)